FDA Approves RHA Filler for Midface Contour Deficiencies
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
Beginning in 2027, RECELL procedures will have four billing codes instead of eight, along with nationally established values for calculating Medicare physician payment.